Download
https://www.ndtvprofit.com/business/biocon-one-of-indias-top-pharma-stocks-cant-focus-on-india?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
“I don’t want to play a bloodbath game in the Indian market, for now,” says Biocon’s Kiran Mazumdar-Shaw.
Share